Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma

Overview of attention for article published in New England Journal of Medicine, October 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news: 73 news outlets
blogs: 1 blog
policy: 2 policy sources
twitter: 49 X users

patent: 2 patents
facebook: 3 Facebook pages
reddit: 1 Redditor
guideline: 5 clinical guideline sources

Readers on

mendeley: 178 Mendeley

So far, Altmetric has seen 79 news stories from 73 outlets.

MSK Research Highlights, December 18, 2024

EurekAlert!, 18 Dec 2024

image: An MSK reseacher working in the lab. view more Credit: Memorial Sloan Kettering Cancer Center New research from Memorial…

MSK Research Highlights, December 18, 2024

Newswise, 18 Dec 2024

New research from Memorial Sloan Kettering Cancer Center (MSK) uncovers clues about how cells control a key DNA repair protein…

Immunocore : Corporate Presentation – August 2024

MarketScreener, 04 Sep 2024

Transformative immunomodulating medicines for patients August 2024 Harnessing the immune system to fight disease with targeted…

Immunocore : Corporate Presentation – June 2024

MarketScreener, 19 Jun 2024

Transformative immunomodulating medicines for patients June 2024 Forward Looking Statements This presentation contains "forward-l…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 75 additional news stories.